false
zh-CN,zh-TW,en,fr,de,ja,ko,pt,es,th,vi
Catalog
2023 ACMG Annual Clinical Genetics Meeting Digital ...
Characterization of Clinically Diagnosed Androgen ...
Characterization of Clinically Diagnosed Androgen Insensitivity Syndrome (AIS) and its Mimics
Back to course
Pdf Summary
The study focuses on the characterization of Androgen Insensitivity Syndrome (AIS) and its mimics, as well as the potential misdiagnosis rate of AIS. AIS is a Differences of Sex Development (DSD) condition that ranges from complete to partial and is commonly seen in individuals with a 46 XY karyotype. The study aims to determine the misdiagnosis rate of AIS at an academic medical center and identify factors that may contribute to inaccurate clinical diagnoses. <br /><br />The researchers conducted a retrospective chart review of 32 patients with clinical diagnoses of AIS using ICD-9/ICD-10 codes. They found that some individuals who were clinically diagnosed with AIS actually had a different DSD upon genetic testing. In particular, they highlight cases of misdiagnosed AIS that were actually androgen biosynthesis defects, such as 5-alpha reductase deficiency, 17-alpha hydroxylase/17,20-lyase deficiency, and 17-beta hydroxysteroid dehydrogenase 3 deficiency.<br /><br />The study emphasizes the importance of genetic testing in accurately diagnosing DSDs and providing patients with personalized genetic counseling and medical management. It also highlights the need for attention to psychosocial implications and the impact of misdiagnosis on patients.<br /><br />The limitations of the study include a small sample size from a single medical institution, which may not fully represent the misdiagnosis rate in practice. The study was funded by the Georgia Association of Genetic Counselors.<br /><br />In conclusion, the study sheds light on the phenotypic overlap between AIS and its mimics, highlighting the need for accurate diagnosis through genetic testing. This can guide appropriate medical and psychosocial management and assess the recurrence risk. The study aims to educate healthcare providers about the importance of genetics testing for patients with DSDs and explore patient perspectives and psychosocial impacts of misdiagnosis.
Asset Subtitle
Presenting Author - Brynn Shrom, BS; Co-Author - Hong H. Li, MD, PhD; Co-Author - Eileen Barr, MS, CGC; Co-Author - Lauren Lichten, MS, CGC;
Meta Tag
Clinical Cytogenetics
Congenital Anomaly
Counseling
Cytogenetics
Differentiation
Dysmorphology
Etiology
Genetic Diversity
Genetic Testing
Genitourinary malformations
Genotype-Phenotype Correlations
Molecular Cytogenetics
Phenotype
Phenotypic delineation of disorders
Psychosocial Counseling Issues
Psychosocial Issues
Sequencing
X-Inactivation/X-Linked Disease
Co-Author
Hong H. Li, MD, PhD
Co-Author
Eileen Barr, MS, CGC
Co-Author
Lauren Lichten, MS, CGC
Presenting Author
Brynn Shrom, BS
Keywords
Androgen Insensitivity Syndrome
AIS
Differences of Sex Development
DSD
misdiagnosis rate
genetic testing
androgen biosynthesis defects
genetic counseling
medical management
psychosocial implications
© 2025 American College of Medical Genetics and Genomics. All rights reserved.
×